| Authors: |
Hyams C; Bristol Vaccine Centre, University of Bristol, Bristol, UK catherine.hyams@bristol.ac.uk.; Academic Respiratory Unit, Department of Clinical Sciences, Bristol University, Bristol, UK., Challen R; Bristol Vaccine Centre, University of Bristol, Bristol, UK.; Engineering Mathematics, University of Bristol, Bristol, UK., Lahuerta M; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA., Begier E; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA., McGuinness S; Bristol Vaccine Centre, University of Bristol, Bristol, UK., Clout M; Bristol Vaccine Centre, University of Bristol, Bristol, UK., Southern J; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA., Campling J; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA., Oliver J; Bristol Vaccine Centre, University of Bristol, Bristol, UK., Theilacker C; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA., Ellsbury G; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA., Maskell N; Academic Respiratory Unit, Department of Clinical Sciences, Bristol University, Bristol, UK.; North Bristol Lung Centre, Southmead Hospital, Bristol, UK., Gessner BD; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA., Danon L; Bristol Vaccine Centre, University of Bristol, Bristol, UK.; Engineering Mathematics, University of Bristol, Bristol, UK., Finn A; Bristol Vaccine Centre, University of Bristol, Bristol, UK. |
